Oncternal Therapeutics, Inc. – Company Profile and SWOT Analysis

Oncternal Therapeutics, Inc. – Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Oncternal Therapeutics, Inc. (Oncternal Therapeutics or 'the company') produces and markets diverse pipeline of product candidates for the treatment of cancers with critical unmet medical need. Its product portfolio includes cirmtuzumab, an anti-ROR1 antibody for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), TK216, a small molecule that is designed to inhibit the ETS or E26 Transformation Specific, family of oncoproteins. Oncternal is also developing a chimeric antigen receptor T cell or CAR-T, therapy candidate that targets ROR1 CAR-T program targeting ROR1 for hematologic cancers and solid tumors. The company is headquartered in San Diego, California, the US.

Scope

– Detailed information on Oncternal Therapeutics, Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Oncternal Therapeutics, Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Oncternal Therapeutics, Inc. including a breakdown and examination of key business segments

– Intelligence on Oncternal Therapeutics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Oncternal Therapeutics, Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Oncternal Therapeutics, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Oncternal Therapeutics, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Oncternal Therapeutics, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Oncternal Therapeutics, Inc.: Company Overview

Oncternal Therapeutics, Inc.: Overview and Key Facts

Oncternal Therapeutics, Inc.: Overview

Oncternal Therapeutics, Inc.: Key Facts

Oncternal Therapeutics, Inc.: Key Employees

Oncternal Therapeutics, Inc.: Key Employee Biographies

Oncternal Therapeutics, Inc.: Major Products and Services

Oncternal Therapeutics, Inc.: Management Statement

Oncternal Therapeutics, Inc.: Key Competitors

Oncternal Therapeutics, Inc.: Company Analysis

Oncternal Therapeutics, Inc.: Business Description

Oncternal Therapeutics, Inc.: SWOT Analysis

Oncternal Therapeutics, Inc.: SWOT Overview

Oncternal Therapeutics, Inc.: Strengths

Oncternal Therapeutics, Inc.: Weaknesses

Oncternal Therapeutics, Inc.: Opportunities

Oncternal Therapeutics, Inc.: Threats

Oncternal Therapeutics, Inc.: Corporate Financial Deals Activity

Oncternal Therapeutics, Inc.: Financial Deals Overview

Oncternal Therapeutics, Inc.: Targets and Partners

Oncternal Therapeutics, Inc.: Top Deals 2020 - 2024YTD*

Oncternal Therapeutics, Inc.: Advisors

Oncternal Therapeutics, Inc.: Top Legal Advisors

Oncternal Therapeutics, Inc.: Top Financial Advisors

Oncternal Therapeutics, Inc.: Capital Raising

Oncternal Therapeutics, Inc.: Partnership

Oncternal Therapeutics, Inc.: Recent Developments

Oncternal Therapeutics, Inc.: News and Events Summary

Oncternal Therapeutics, Inc.: Contracts

Oncternal Therapeutics, Inc.: Corporate Governance

Oncternal Therapeutics, Inc.: Financial Performance

Oncternal Therapeutics, Inc.: Market Developments

Oncternal Therapeutics, Inc.: Research & Development

Oncternal Therapeutics, Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Oncternal Therapeutics, Inc.: Key Facts

Table 2: Oncternal Therapeutics, Inc.: Key Employees

Table 3: Oncternal Therapeutics, Inc.: Key Competitors

Table 4: Oncternal Therapeutics, Inc.: Deal Activity by Deal Type – Volume (2020 – YTD*2024)

Table 5: Oncternal Therapeutics, Inc.: Targets and Partners

Table 6: Oncternal Therapeutics, Inc.: Top Deals 2020 – 2024YTD*

Table 7: Oncternal Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)

Table 8: Oncternal Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)

Table 9: Oncternal Therapeutics, Inc.: Capital Raising Volume and Value Trend (2020 – YTD*2024)

Table 10: Oncternal Therapeutics, Inc.: Capital Raising by Deal Type (2020 – YTD*2024)

Table 11: Oncternal Therapeutics, Inc.: Partnership Volume and Value Trend (2020 – YTD*2024)

Table 12: Oncternal Therapeutics, Inc.: Partnership Trend by Deal Type (2020 – YTD*2024)

Table 13: Oncternal Therapeutics, Inc.: News and Events Summary

Table 14: Oncternal Therapeutics, Inc.: Contracts

Table 15: Oncternal Therapeutics, Inc.: Corporate Governance

Table 16: Oncternal Therapeutics, Inc.: Financial Performance

Table 17: Oncternal Therapeutics, Inc.: Market Developments

Table 18: Oncternal Therapeutics, Inc.: Research & Development

Table 19: Oncternal Therapeutics, Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Oncternal Therapeutics, Inc.: Deal Activity by Deal Type – Volume (2020 – YTD*2024)

Figure 2: Oncternal Therapeutics, Inc.: Capital Raising Volume and Value Trend (2020 – YTD*2024)

Figure 3: Oncternal Therapeutics, Inc.: Capital Raising by Deal Type (2020 – YTD*2024)

Figure 4: Oncternal Therapeutics, Inc.: Partnership Volume and Value Trend (2020 – YTD*2024)

Figure 5: Oncternal Therapeutics, Inc.: Partnership Trend by Deal Type (2020 – YTD*2024)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports